Atorvastatin

Pharmacogenomic Information in the Context of the FDA-Approved Drug Label*

Although the atorvastatin drug label does not specifically mention genetic testing, atorvastatin is indicated for treatment of familial hypercholesterolemia, a genetically determined condition.

Excerpt from the atorvastatin drug label:

"LIPITOR is indicated: 1. As an adjunct to diet to reduce elevated total-C, LDL-C, apoB, and TG levels and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and non-familial) ... 4. To reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or if such treatments or unavailable ..."

For the complete drug label text with sections containing pharmacogenetic information highlighted, see the Atorvastatin drug label PDF.

Related PharmGKB Resources